CASTLE BIOSCIENCES, INC. (CSTL) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
CASTLE BIOSCIENCES, INC. (CSTL) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 561,177,000 US dollars
- Current assets
- 341,100,000 US dollars
- Non-current assets
- 220,077,000 US dollars
- Liabilities
- 91,147,000 US dollars
- Current liabilities
- 56,509,000 US dollars
- Non-current liabilities
- 34,638,000 US dollars
- Equity
- 470,030,000 US dollars
- Marketable investment securities
- 204,689,000 US dollars
- Cash and cash equivalents
- 62,116,000 US dollars
- Accounts receivable, net
- 48,341,000 US dollars
- Prepaid expenses and other current assets
- 15,374,000 US dollars
- Inventory
- 10,580,000 US dollars
- Property and equipment, net
- 104,682,000 US dollars
- Goodwill and other intangible assets, net
- 95,096,000 US dollars
- Operating lease assets
- 14,196,000 US dollars
- Other assets – long-term
- 4,442,000 US dollars
- Long-term accounts receivable, net
- 1,661,000 US dollars
- Accrued compensation
- 26,893,000 US dollars
- Other accrued and current liabilities
- 14,114,000 US dollars
- Accounts payable
- 9,668,000 US dollars
- Current portion of long-term debt
- 2,917,000 US dollars
- Contingent consideration
- 1,500,000 US dollars
- Operating lease liabilities
- 1,417,000 US dollars
- Noncurrent operating lease liabilities
- 24,894,000 US dollars
- Long-term debt
- 7,158,000 US dollars
- Deferred tax liability
- 2,322,000 US dollars
- Noncurrent finance lease liabilities
- 264,000 US dollars
- Noncurrent portion of contingent consideration
- 0 US dollars
- Additional paid-in capital
- 711,121,000 US dollars
- Common stock, $0.001 par value per share; 200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 30,508,534 and 29,686,314 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
- 31,000 US dollars
- Preferred stock, $0.001 par value per share; 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued and outstanding as of June 30, 2026 and December 31, 2025
- 0 US dollars
- Accumulated deficit
- negative 240,866,000 US dollars
- Accumulated other comprehensive (loss) income
- negative 256,000 US dollars
- Gross equity (calculated)
- 711,152,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
